ENRICHMENT AND DETECTION METHODOLOGIES FOR EGFR PHOSPHOPEPTIDES

EGFR 磷酸肽的富集和检测方法

基本信息

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Epidermal growth factor receptor (EGFR) tyrosine kinase plays an important role in regulating cell growth, proliferation, and migration. Differential phosphorylation of specific tyrosine residues in EGFR in response to diverse external stimuli (e.g., exposure to EGF, ATP, cell injury, etc.) serves as the key link between these stimuli and the internal signaling pathways that they activate. EGFR phosphosite-specific antibodies have been used as highly sensitive tools to monitor phosphorylation site occupancy, however, they suffer from a lack of specificity. Recently, highly sensitive mass spectrometric-based detection strategies have been described to characterize the EGFR tyrosine phosphorylation cascade under a variety of conditions. Currently, many phosphopeptide enrichment methods are in use, including immunoprecipitation of phosphoproteins/peptides with specific antibodies, strong cation exchange chromatography, electrostatic repulsion hydrophilic interaction chromatography, immobilized metal affinity chromatography, zirconium dioxide and titanium dioxide chromatography. Used independently, each of these methods does increase the efficiency of detection for phosphopeptides;each has advantages and limitations. Combining different phosphopeptide enrichment methods is, therefore, crucial for a more comprehensive detection of phosphopeptides in complex biological samples. In our most recent experiments, Human Corneal Limbal Epithelial cell lines (HCLEs) were grown to confluence, stimulated with EGF, and lysed with 8M urea supplemented with phosphatase and protease inhibitors. For quantitative phosphorylation analyses, stable isotope-labeled cells were used. An average of 10 mg total protein was reduced, alkylated and digested with trypsin. Peptides were desalted with SepPak C18 reversed phase chromatography. Phosphotyrosine peptides were immunoprecipitated using a combination of three anti-phosphotyrosine antibodies. The flow-through was further fractionated with either electrostatic repulsion hydrophilic interaction chromatography (ERLIC) or strong cation exchange (SCX) chromatography. Fractions were further phosphoenriched using immobilized metal affinity chromatography (IMAC) and analyzed by LC/MSn using a nanoAcuity UPLC (Waters) coupled through a TriVersa NanoMate (Advion) to an LTQ-Orbitrap MS (Thermo-Fisher). When employed alone, SCX chromatographic fractionation of samples, resulted in low detection efficiency for phosphopeptides. The relatively high amount of non-phosphopeptides in the SCX fractions outcompeted the phosphopeptides for detection. Further phospho-based enrichment of the SCX fractions with either IMAC or TiO2 chromatography eliminated most of the non-phosphopeptides and significantly increased detection efficiency for the phosphopeptides. In a parallel experiment, we fractionated peptides using ERLIC and analyzed the resulting fractions directly by LC/MS/MS. ERLIC alone provided significantly increased detection of phosphopeptides. Given the low stoichiometry of phosphotyrosine compared to phosphoserine or phosphothreonine in biological samples, however, their detection level of remains a challenge. Further reasearch is presently underway to increase the detection efficiency for phosphotyrosine peptides. Our current approach employs immunoprecipitation of phosphotyrosine peptides prior to fractionation by either SCX or ERLIC. The flow-through is then divided in to two and fractionated further - one half is subjected to SCX and the other half to ERLIC. All the immunoprecipitated peptides, the SCX and ERLIC fractions are further phosphoenriched using IMAC before LC/MSn analysis.
这个子项目是利用这些资源的众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Vickery E Trinkaus-Randall其他文献

Vickery E Trinkaus-Randall的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Vickery E Trinkaus-Randall', 18)}}的其他基金

Molecular Mechanisms of corneal wound repair
角膜伤口修复的分子机制
  • 批准号:
    10674734
  • 财政年份:
    2021
  • 资助金额:
    $ 5.08万
  • 项目类别:
Molecular Mechanisms of corneal wound repair
角膜伤口修复的分子机制
  • 批准号:
    10296958
  • 财政年份:
    2021
  • 资助金额:
    $ 5.08万
  • 项目类别:
Molecular Mechanisms of corneal wound repair
角膜伤口修复的分子机制
  • 批准号:
    10470861
  • 财政年份:
    2021
  • 资助金额:
    $ 5.08万
  • 项目类别:
Multicellular regulation of corneal wound healing
角膜伤口愈合的多细胞调节
  • 批准号:
    8975202
  • 财政年份:
    2014
  • 资助金额:
    $ 5.08万
  • 项目类别:
AFM AND MS TO MONITOR FIBRIL FORMATION FROM AMYLOID IG LIGHT CHAINS AND GAGS
AFM 和 MS 监测淀粉样蛋白 IG 轻链和 GaGS 的纤维形成
  • 批准号:
    8365539
  • 财政年份:
    2011
  • 资助金额:
    $ 5.08万
  • 项目类别:
AFM AND MS TO MONITOR FIBRIL FORMATION FROM AMYLOID IG LIGHT CHAINS AND GAGS
AFM 和 MS 监测淀粉样蛋白 IG 轻链和 GaGS 的纤维形成
  • 批准号:
    8170907
  • 财政年份:
    2010
  • 资助金额:
    $ 5.08万
  • 项目类别:
ENRICHMENT AND DETECTION METHODOLOGIES FOR EGFR PHOSPHOPEPTIDES
EGFR 磷酸肽的富集和检测方法
  • 批准号:
    8170926
  • 财政年份:
    2010
  • 资助金额:
    $ 5.08万
  • 项目类别:
ENRICHMENT AND DETECTION METHODOLOGIES FOR EGFR PHOSPHOPEPTIDES
EGFR 磷酸肽的富集和检测方法
  • 批准号:
    7955962
  • 财政年份:
    2009
  • 资助金额:
    $ 5.08万
  • 项目类别:
AFM AND MS TO MONITOR FIBRIL FORMATION FROM AMYLOID IG LIGHT CHAINS AND GAGS
AFM 和 MS 监测淀粉样蛋白 IG 轻链和 GaGS 的纤维形成
  • 批准号:
    7955940
  • 财政年份:
    2009
  • 资助金额:
    $ 5.08万
  • 项目类别:
AFM TO MONITOR FIBRIL FORMATION FROM AMYLOID IG LIGHT CHAINS
AFM 监测淀粉样蛋白 IG 轻链的纤维形成
  • 批准号:
    7723045
  • 财政年份:
    2008
  • 资助金额:
    $ 5.08万
  • 项目类别:

相似海外基金

Development of blood-brain barrier-crossing antibodies utilizing the biological features of glucose transporters
利用葡萄糖转运蛋白的生物学特性开发血脑屏障跨越抗体
  • 批准号:
    21K18268
  • 财政年份:
    2021
  • 资助金额:
    $ 5.08万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Pioneering)
Development of Minimally Invasive MR Imaging Method for biological materials Using Carbon-13 Labeled Antibodies
使用碳 13 标记抗体开发生物材料微创 MR 成像方法
  • 批准号:
    21K07568
  • 财政年份:
    2021
  • 资助金额:
    $ 5.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Sex as a Biological Variable Supplement - Neutralizing human-derived single-chain antibodies against SARS-CoV-2
性别作为生物变量补充剂 - 中和人源性单链抗 SARS-CoV-2 抗体
  • 批准号:
    424696
  • 财政年份:
    2020
  • 资助金额:
    $ 5.08万
  • 项目类别:
    Operating Grants
Modulation of cardiac cell signaling with synthetic antibodies, and their characterization as potential therapeutics and probes for basic biological research
用合成抗体调节心脏细胞信号传导,及其作为基础生物学研究潜在疗法和探针的表征
  • 批准号:
    366643
  • 财政年份:
    2016
  • 资助金额:
    $ 5.08万
  • 项目类别:
    Operating Grants
Biological Significance of Protamine/Heparin Antibodies
鱼精蛋白/肝素抗体的生物学意义
  • 批准号:
    8868489
  • 财政年份:
    2015
  • 资助金额:
    $ 5.08万
  • 项目类别:
Biological Significance of Protamine/Heparin Antibodies
鱼精蛋白/肝素抗体的生物学意义
  • 批准号:
    9136851
  • 财政年份:
    2015
  • 资助金额:
    $ 5.08万
  • 项目类别:
Biological Significance of Protamine/Heparin Antibodies
鱼精蛋白/肝素抗体的生物学意义
  • 批准号:
    9294104
  • 财政年份:
    2015
  • 资助金额:
    $ 5.08万
  • 项目类别:
Understanding biological ignificance of histone modifications by epigenetic manipulation using multifunctional antibodies
使用多功能抗体通过表观遗传操作了解组蛋白修饰的生物学意义
  • 批准号:
    26291071
  • 财政年份:
    2014
  • 资助金额:
    $ 5.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Biological Significance of Protatmine/Heparin Antibodies
鱼精蛋白/肝素抗体的生物学意义
  • 批准号:
    8592644
  • 财政年份:
    2013
  • 资助金额:
    $ 5.08万
  • 项目类别:
Analysis of biological function and efficacy of anti EGFR antibodies isolated from screening of human antibody phage display library specific to human renal cell carcinoma
人肾细胞癌特异性抗体噬菌体展示库筛选分离抗EGFR抗体的生物学功能和功效分析
  • 批准号:
    20591870
  • 财政年份:
    2008
  • 资助金额:
    $ 5.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了